Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s disease is a research paper published in Molecular Therapy (2022). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Deutsche Forschungsgemeinschaft
Grant: PA 1529/2-1
National Institute of Environmental Health Sciences
Grant: /NIEHS R01 ES016931
Fondazione Telethon
Grant: GGP20101
European Huntington's Disease Network
Grant: 903
NIEHS NIH HHS
Grant: R01 ES016931
National Institutes of Health
FWCI
1.38
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords